Moleculin Biotech, Inc. (NASDAQ:MBRX) Q2 2023 Earnings Call Transcript August 11, 2023
Moleculin Biotech, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.28.
Operator: Hello, and welcome to the Moleculin Biotech Quarterly Update Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to your host, Jenene Thomas, Investor Relations. Please go ahead, Jenene.
Jenene Thomas:...
